VOYA INVESTMENT MANAGEMENT LLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 8.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$536,000
+60.0%
14,235
-27.7%
0.00%0.0%
Q4 2020$335,000
+95.9%
19,691
-45.9%
0.00%
Q3 2020$171,000
-24.0%
36,391
-1.3%
0.00%
-100.0%
Q2 2020$225,000
+423.3%
36,889
+92.9%
0.00%
Q1 2020$43,000
-51.1%
19,1220.0%0.00%
Q4 2019$88,000
+60.0%
19,122
+35.3%
0.00%
Q3 2019$55,000
-35.3%
14,1300.0%0.00%
Q2 2019$85,000
-55.0%
14,1300.0%0.00%
Q1 2019$189,000
+44.3%
14,1300.0%0.00%
Q4 2018$131,000
-33.5%
14,1300.0%0.00%
Q3 2018$197,000
-11.7%
14,1300.0%0.00%
Q2 2018$223,000
+3.2%
14,130
+12.2%
0.00%
Q1 2018$216,000
-21.7%
12,5940.0%0.00%
-100.0%
Q4 2017$276,000
-46.4%
12,5940.0%0.00%0.0%
Q3 2017$515,000
+35.9%
12,5940.0%0.00%0.0%
Q2 2017$379,000
-8.9%
12,594
+9.5%
0.00%0.0%
Q1 2017$416,000
-27.8%
11,4970.0%0.00%0.0%
Q4 2016$576,000
-4.5%
11,4970.0%0.00%0.0%
Q3 2016$603,000
+26.9%
11,4970.0%0.00%0.0%
Q2 2016$475,000
+20.9%
11,497
+19.0%
0.00%0.0%
Q1 2016$393,000
-2.0%
9,6620.0%0.00%0.0%
Q4 2015$401,000
+26.9%
9,662
-24.0%
0.00%0.0%
Q2 2015$316,000
+9.0%
12,7050.0%0.00%0.0%
Q1 2015$290,000
-15.5%
12,7050.0%0.00%0.0%
Q4 2014$343,000
+130.2%
12,7050.0%0.00%
Q3 2014$149,000
-24.7%
12,7050.0%0.00%
Q2 2014$198,00012,7050.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,092,152$16,808,219,0009.64%
GREAT POINT PARTNERS LLC 1,226,785$18,880,0007.47%
Ghost Tree Capital, LLC 500,000$7,695,0003.46%
RTW INVESTMENTS, LP 713,954$10,988,0003.41%
ARMISTICE CAPITAL, LLC 506,000$7,787,0002.66%
EcoR1 Capital, LLC 149,000$2,293,0001.04%
Eventide Asset Management 1,164,900$17,928,0001.04%
Telemetry Investments, L.L.C. 102,500$1,577,0000.68%
J. Goldman & Co LP 313,527$4,825,0000.41%
AWM Investment Company, Inc. 118,199$1,819,0000.35%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders